Your browser doesn't support javascript.
loading
Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges.
Qiao, Luyao; Liu, Xin; Shang, Junmei; Zuo, Wei; Xu, Tingting; Qu, Jinghan; Jiang, Jiandong; Zhang, Bo; Zhang, Shuyang.
Afiliação
  • Qiao L; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Liu X; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Shang J; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Zuo W; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Xu T; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
  • Qu J; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Jiang J; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Zhang B; Department of Pharmacy and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Dongdan Campus No. 1 Shuaifuyuan Wangfujing Dongcheng District, Beijing, 100730, China.
  • Zhang S; State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.
Orphanet J Rare Dis ; 17(1): 352, 2022 09 10.
Article em En | MEDLINE | ID: mdl-36088349
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produção de Droga sem Interesse Comercial / Doenças Raras Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produção de Droga sem Interesse Comercial / Doenças Raras Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Orphanet J Rare Dis Assunto da revista: MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido